2009
DOI: 10.1093/rheumatology/ken501
|View full text |Cite
|
Sign up to set email alerts
|

Association between the interleukin 23 receptor and ankylosing spondylitis is confirmed by a new UK case-control study and meta-analysis of published series

Abstract: IL-23R polymorphisms are clearly associated with AS, but the primary causal association(s) is(are) still not established. These polymorphisms could contribute either increased or decreased susceptibility to AS; functional studies will be required for their full evaluation. Additionally, observed stronger associations with SNPs rs11209026 and rs11465804 upon exclusion of IBD and/or psoriasis cases may represent an independent association with AS.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
76
2

Year Published

2009
2009
2020
2020

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 98 publications
(83 citation statements)
references
References 15 publications
5
76
2
Order By: Relevance
“…This illustrates the potential central role of the IL-23/IL-17 axis in AS [2], and is concordant with other findings, such as IL-23 receptor polymorphisms in AS, as well as in Crohn's disease or in psoriasis [3], sharing the concept of spondyloarthropathy. Elevated IL-17 levels were found in the serum of AS patients [4], and increased numbers of Th 17 cells in the peripheral blood of patients with seronegative spondylarthritides (and not RA) were reported by Jandus [5], as well as increased frequencies of IL-17 positive CD4?…”
Section: Sirsupporting
confidence: 91%
“…This illustrates the potential central role of the IL-23/IL-17 axis in AS [2], and is concordant with other findings, such as IL-23 receptor polymorphisms in AS, as well as in Crohn's disease or in psoriasis [3], sharing the concept of spondyloarthropathy. Elevated IL-17 levels were found in the serum of AS patients [4], and increased numbers of Th 17 cells in the peripheral blood of patients with seronegative spondylarthritides (and not RA) were reported by Jandus [5], as well as increased frequencies of IL-17 positive CD4?…”
Section: Sirsupporting
confidence: 91%
“…Wordsworth reviewed results from the Wellcome Trust Case-Control Consortium (WTCCC) GWAS, particularly the involvement of ERAP1 (also know as ARTS 1) and IL23R with AS 41 . The Oxford Spondyloarthropathy Research Group extended the WTCCC study of IL23R to 730 further AS cases and combined their results in a metaanalysis, which confirmed the association with AS (rs11209026; OR = 0.61, p < 10 -10 ) 42 . This association is robust to stratification on the presence of IBD and/or psoriasis, indicating that the association with this coding SNP is likely to be the primary association with AS 42 .…”
Section: Genetics Of Enteropathic Arthritismentioning
confidence: 75%
“…The Oxford Spondyloarthropathy Research Group extended the WTCCC study of IL23R to 730 further AS cases and combined their results in a metaanalysis, which confirmed the association with AS (rs11209026; OR = 0.61, p < 10 -10 ) 42 . This association is robust to stratification on the presence of IBD and/or psoriasis, indicating that the association with this coding SNP is likely to be the primary association with AS 42 . Other genes that are associated with both IBD and AS include CARD9, an important component of the innate immune system, linking infection and NF-kB activation 43 .…”
Section: Genetics Of Enteropathic Arthritismentioning
confidence: 75%
“…The non-synonymous rs11209026 SNP (R381Q) in the IL-23R gene was found to provide a strong shield against CD. However, results from a study of patients with AS in the United Kingdom revealed that the IL-23R (rs11209032) SNP was most strongly associated with IBD (p<0.001) (30). In a Spanish study, associations with IL23-R SNPs were observed to exert a protective effect against IBD (rs1343151, p<0.0002; rs11209026, p<0.001; and rs10889677, p<0.04).…”
Section: Discussionmentioning
confidence: 95%